Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa

Journal of Clinical Virology

Volumn 27, Issue 2, 2003, Pages 180-189

  Madhi, Shabir A ^a   Venter, Marietjie ^b   Alexandra, Richard ^c   Lewis, Humphrey ^d   Kara, Yatish ^e   Karshagen, William F ^f   Greef, Michael ^g   Lassen, Cheryl ^h  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d Panorama Medi Clinic   (South Africa)

^e Pretoria Gynaecological Hospital   (South Africa)

^f St Augustine Heart Care Hospital   (South Africa)

^g UNIVERSITY OF THE FREE STATE   (South Africa)

^h ABBOTT LABORATORIES   (United States)

Author keywords

Genotype; High risk; Pneumonia; RSV; Subtype

Indexed keywords

ARTICLE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; LUNG ASPIRATION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SOUTH AFRICA; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHYLOGENY; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; RNA, VIRAL; SEASONS; SOUTH AFRICA;

EID: 0142258773     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00174-9     Document Type: Article

References (27)

1. Cane P.A. Molecular epidemiology of respiratory syncytial virus. Rev. Med. Virol. 11:2001;103-116.
2. Cane P., Matthews D., Pringle C. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J. Gen. Virol. Sep. 72:1991;2091-2096.
3. Cane P.A., Matthews D.A., Pringle C.R. Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide. Virus Res. 25:1992;15-22.
4. Choi E., Lee H. Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over nine consecutive epidemics in Korea. J. Infect. Dis. 181:(5):2000;1547-1556.
5. Felsenstein J. PHYLIP (Phylogeny Inference Package) Version 3.5c. 1993;Department of Genetics, University of Washington, Seattle.
6. Garcia O., Martin M., Dopazo J., Arbiza J., Frabasile S., Russi J., Hortal M., Perez-Brena P., Martinez I., Garcia-Barreno B., et al. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G-glycoprotein. J. Virol. 68:1994;5448-5459.
7. Glezen W.P., Denny F.W. Epidemiology of acute lower respiratory diseases in children. New Engl. J. Med. 288:1973;498-505.
8. Holberg C.J., Wright A.L., Martinez F.D., Ray C.G., Taussig L.M., Lebowitz M.D. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am. J. Epidiol. 133:1991;1135-1151.
9. Hussey G.D., Apolles P., Arendse Z., Yeates J., Robertson A., Swingler G., Zar H. Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection. SAMJ. 90:2000;509-512.
10. Johnson P.J., Olmsted R., Prince G., Murphy B., Alling D., Walsh E., Collins P. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J. Virol. 61:1987;3163-3166.
11. Kumar S., Tamura K., Jakobsen I., Nei M. MEGA: Molecular Evolutionary Genetics Analyses. Version 2.0. 2000;Pennsylvania State University, University Park.
12. Madhi S.A., Schoub B., Simmank K., Blackburn N., Klugman K.P. Increased burden of respiratory virus associated severe lower respiratory tract infections in HIV-1 infected children. J. Pediatr. 137:2000;78-84.
13. Madhi S.A., Venter M., Madhi A., Petersen M.K., Klugman K.P. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr. Infect. Dis. J. 20:2001;164-170.
14. Martinez I., Valdes O., Delfraro A., Arbiza J., Russi J., Melero J.A. Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J. Gen. Virol. 80:1999;125-130.
15. Peret T.C., Hall C.B., Schnabel K.C., Golub J.A., Anderson L.J. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol. 79:1998;2221-2229.
16. Peret T.C., Hall C.B., Hammond G.W., Piedra P.A., Storch G.A., Sullender W.M., Tsou C., Anderson L.J. Circulation patterns of group A and B human respiratory syncytial virus genotypes in five communities in North America. J. Infect. Dis. 181:2000;1891-1896.
17. Roca A., Loscertales M.P., Quinto L., Perez-Brena P., Vaz N., Alonso P.L., Saiz J.C. Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates. J. Gen. Virol. 82:2001;103-111.
18. Selwyn B.J. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev. Infect. Dis. 12:(suppl 8):1990;S870-S888.
19. Sullender W.M., Mufson M.A., Anderson L.J., Wertz G.W. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J. Virol. 65:1991;5425-5434.
20. Sullender W.M., Sun L., Anderson L.J. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J. Clin. Microbiol. 31:1993;1224-1231.
21. Sullender W.M., Mufson M., Prince G., Anderson L.J., Wertz G.W. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J. Infect. Dis. 178:(4):1998;925-932.
22. Palivizuamb, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection in high-risk infants. Pediatrics. 102:1998;531-537.
23. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:1997;4876-4882.
24. Venter M., Madhi S.A., Tiemessen C.T., Schoub B.D. Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J. Gen. Virol. 82:2001;2117-2124.
25. Venter M., Collinson M., Schoub B.D. Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations. J. Med. Virol. 68:(3):2002;452-461.
26. Wang E.E.L., Law B.J., Stephens D. Pediatric investigators collaborative network in infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J. Pediatr. 126:1995;212-219.
27. Wertz G.W., Collins P.L., Huang Y., Gruber C., Levine S., Ball L.A. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc. Natl. Acad. Sci. USA. 82:1985;4075-4079.